Thursday, October 25, 2012

Report: NECC operated on manufacturing scale, failed in quality Read more: Pharma Manufacturing, Pharmaceutical Manufacturing - Fierce Pharma Manufacturing http://www.fiercepharmamanufacturing.com/#ixzz2ALxdsfRl Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing


The initial report from the Massachusetts Board of Registration in Pharmacy shows that New England Compounding Center was operating like a small drug manufacturing plant but without following the strict quality and safety oversight that would come if it had been treated like a manufacturer and regularly inspected by the FDA.


Read more: Pharma Manufacturing, Pharmaceutical Manufacturing - Fierce Pharma Manufacturing http://www.fiercepharmamanufacturing.com/#ixzz2ALxk22nl
Subscribe: http://www.fiercepharmamanufacturing.com/signup?sourceform=Viral-Tynt-FiercePharma Manufacturing-FiercePharma Manufacturing

No comments: